Bacterial extracellular vesicles offer a versatile platform for targeted drug delivery, immunotherapy, cancer vaccines, biomarker discovery, and tumor monitoring in precision oncology...
Read More »Engineered bacterial extracellular vesicles may advance precision postbiotics
Engineered extracellular vesicles and exosomes derived from bacteria may improve targeted delivery, postbiotic therapies, and precision medicine...
Read More »Genetically engineered L. plantarum produces extracellular vesicles that improve therapy for inflammatory bowel disease
Genetically engineered Lactiplantibacillus plantarum produces high-yield bacterial extracellular vesicles that effectively reduce intestinal inflammation and repair tissue, offering a promising new approach for IBD
Read More »Bacterial extracellular vesicles show promise as a new treatment for bladder cancer
Researchers demonstrate that bacterial extracellular vesicles can safely and effectively shrink bladder tumors, outperforming standard BCG therapy...
Read More »IgA-coated extracellular vesicles drive inflammation in ulcerative colitis
Extracellular vesicles released by gut bacteria, coated with IgA antibodies, play a key role in triggering inflammation in ulcerative colitis...
Read More »
Exosome RNA Exosome RNA Research & Industry News
